GSK vs LKFN · P/E 13, $103.31B cap vs P/E 19, rev $187.1M
GlaxoSmithKline PLC ADR (GSK) versus Lakeland Financial Corporation (LKFN) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Lakeland Financial Corporation (LKFN) is a banks - regional company listed on US.
GSK does not have a complete income-statement cache yet.
Latest reported LKFN revenue for 2026-06-30 was $187.1M. Net income was $54.9M. LKFN currently screens at market cap $1.67B and trailing P/E 18.6.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. LKFN currently screens at market cap $1.67B and trailing P/E 18.6.
Not investment advice. Open the GSK and LKFN stock pages for the full models.
Not investment advice.